drospirenone has been researched along with Acne in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 19 (65.52) | 29.6817 |
| 2010's | 10 (34.48) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czech, I; Drosdzol-Cop, A; Fuchs, A; Hauzer, A; Matonóg, A; Pilarska, J; Sieradzka, P | 1 |
| Chen, CL; Fitzpatrick, L; Mauer, E | 1 |
| Canu, E; Fulghesu, AM; Melis, F; Melis, GB; Murru, G | 1 |
| Caruso, S; Cianci, A; Cianci, S; Cicero, C; Lo Presti, L; Malandrino, C | 1 |
| Czilli, T; Knezevic, S; Peters, C; Tan, J | 1 |
| Koltun, W; Korner, P; Lucky, AW; Marr, J; Niknian, M; Sampson-Landers, C; Thiboutot, D | 2 |
| Dietze, P; Korner, P; Lee-Rugh, S; Maloney, JM; Niknian, M; Sampson-Landers, C; Watson, D | 2 |
| Mishell, DR | 2 |
| Kimball, AB | 1 |
| Colonna, L; Guardianelli, F; Lello, S; Primavera, G; Raskovic, D; Sorge, R; Vittori, G | 1 |
| Cremer, M; Jacobs, A; Phan-Weston, S | 1 |
| Giribela, AG; Giribela, CG; Machado, RB; Pompei, Lde M | 1 |
| Koltun, W; Kunz, M; Maloney, JM; Marr, J | 1 |
| El-Sherbiny, WS; Mohamed, AM; Mostafa, WA | 1 |
| Korver, T; Mansour, D; Melis, GB; Sommer, W; Sundström-Poromaa, I; Taneepanichskul, S; Verhoeven, C; Weisberg, E | 1 |
| Dickerson, V | 1 |
| Gollnick, H; Schellschmidt, I; Thorneycroft, lH | 1 |
| Rapkin, AJ; Winer, SA | 1 |
| Fenton, C; Moen, MD; Robinson, DM; Wellington, K | 1 |
| Tan, JK | 1 |
| Cagiano, R; Loverro, G; Orsini, G; Sabatini, R | 1 |
| Ciurea, A; Krunic, A; Scheman, A | 1 |
| Rich, P | 1 |
| Rapkin, AJ; Sorger, SN; Winer, SA | 1 |
| Gerlinger, C; Heithecker, R; van Haselen, CW; van Vloten, WA; van Zuuren, EJ | 1 |
8 review(s) available for drospirenone and Acne
| Article | Year |
|---|---|
Recent innovations in oral contraception.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Hormonal; Endometrial Hyperplasia; Estradiol; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperkalemia; Levonorgestrel; Menstrual Cycle; Menstruation Disturbances; Ovulation; Pregnancy; Randomized Controlled Trials as Topic; Thromboembolism; Uterine Hemorrhage | 2010 |
Drospirenone/ethinylestradiol: a review on efficacy and noncontraceptive benefits.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Combined; Dysmenorrhea; Endometrium; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome | 2011 |
Quality of life issues. Potential role for an oral contraceptive containing ethinyl estradiol and drospirenone.
Topics: Acne Vulgaris; Androgen Antagonists; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Mineralocorticoids; Premenstrual Syndrome; Progesterone Congeners; Quality of Life; Randomized Controlled Trials as Topic; Weight Gain | 2002 |
Drospirenone: a novel progestin.
Topics: Acne Vulgaris; Androgen Antagonists; Androstenes; Animals; Clinical Trials as Topic; Contraceptives, Oral, Combined; Drug Combinations; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome; Progesterone Congeners | 2007 |
Drospirenone/ethinylestradiol 3mg/20microg (24/4 day regimen): a review of its use in contraception, premenstrual dysphoric disorder and moderate acne vulgaris.
Topics: Acne Vulgaris; Androstenes; Contraception; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estrogens; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Premenstrual Syndrome | 2007 |
New developments in hormonal therapy for acne.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel | 2007 |
Hormonal contraceptives for acne management.
Topics: Acne Vulgaris; Androstenes; Clinical Trials as Topic; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Mineralocorticoid Receptor Antagonists; Skin | 2008 |
Drospirenone/ethinyl estradiol.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Premenstrual Syndrome | 2008 |
11 trial(s) available for drospirenone and Acne
| Article | Year |
|---|---|
A combined oral contraceptive containing 3-mg drospirenone/ 20-microg ethinyl estradiol in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled study evaluating lesion counts and participant self-assessment.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Middle Aged; Treatment Outcome | 2008 |
Treatment of acne using a 3-milligram drospirenone/20-microgram ethinyl estradiol oral contraceptive administered in a 24/4 regimen: a randomized controlled trial.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Middle Aged; Treatment Outcome | 2008 |
Effects of two estroprogestins containing ethynilestradiol 30 microg and drospirenone 3 mg and ethynilestradiol 30 microg and chlormadinone 2 mg on skin and hormonal hyperandrogenic manifestations.
Topics: 17-alpha-Hydroxyprogesterone; Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Androstenedione; Androstenes; Chlormadinone Acetate; Dehydroepiandrosterone Sulfate; Dermatitis, Seborrheic; Ethinyl Estradiol; Female; Follicle Stimulating Hormone; Hair; Humans; Hyperandrogenism; Luteinizing Hormone; Sex Hormone-Binding Globulin; Skin Diseases; Testosterone; Young Adult | 2008 |
A randomized controlled trial of a low-dose combined oral contraceptive containing 3 mg drospirenone plus 20 microg ethinylestradiol in the treatment of acne vulgaris: lesion counts, investigator ratings and subject self-assessment.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Double-Blind Method; Ethinyl Estradiol; Female; Humans; Middle Aged; Treatment Outcome; Young Adult | 2009 |
Treatment of moderate acne vulgaris using a combined oral contraceptive containing ethinylestradiol 20 μg plus drospirenone 3mg administered in a 24/4 regimen: a pooled analysis.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Double-Blind Method; Estrogens; Ethinyl Estradiol; Female; Humans; Progestins; Severity of Illness Index; Young Adult | 2011 |
Combined contraceptive ring versus combined oral contraceptive (30-μg ethinylestradiol and 3-mg drospirenone).
Topics: Acne Vulgaris; Adolescent; Adult; Affective Symptoms; Androstenes; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Drug Combinations; Ethinyl Estradiol; Female; Humans; Leukorrhea; Libido; Lipoproteins, LDL; Metrorrhagia; Vaginitis; Weight Gain; Young Adult | 2011 |
Efficacy and tolerability of a monophasic combined oral contraceptive containing nomegestrol acetate and 17β-oestradiol in a 24/4 regimen, in comparison to an oral contraceptive containing ethinylestradiol and drospirenone in a 21/7 regimen.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Estradiol; Estrogens; Ethinyl Estradiol; Female; Humans; Megestrol; Menstrual Cycle; Metrorrhagia; Middle Aged; Mineralocorticoid Receptor Antagonists; Norpregnadienes; Pregnancy; Pregnancy Rate; Substance Withdrawal Syndrome; Young Adult | 2011 |
Superiority of a combined contraceptive containing drospirenone to a triphasic preparation containing norgestimate in acne treatment.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Double-Blind Method; Drug Combinations; Ethinyl Estradiol; Female; Humans; Mineralocorticoid Receptor Antagonists; Norgestrel; Prospective Studies; Treatment Outcome | 2004 |
Noncontraceptive benefits of two combined oral contraceptives with antiandrogenic properties among adolescents.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Androstenes; Chlormadinone Acetate; Contraceptives, Oral, Hormonal; Dysmenorrhea; Female; Hair; Humans; Menstrual Cycle; Patient Acceptance of Health Care; Prospective Studies; Sexual Behavior; Skin | 2007 |
Efficacy and safety of 3 mg drospirenone/20 mcg ethinylestradiol oral contraceptive administered in 24/4 regimen in the treatment of acne vulgaris: a randomized, double-blind, placebo-controlled trial.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Double-Blind Method; Ethinyl Estradiol; Humans; Middle Aged; Treatment Outcome | 2008 |
The effect of 2 combined oral Contraceptives containing either drospirenone or cyproterone acetate on acne and seborrhea.
Topics: Acne Vulgaris; Adolescent; Adult; Androgen Antagonists; Androstenes; Contraceptives, Oral, Combined; Cyproterone; Dermatitis, Seborrheic; Double-Blind Method; Drug Administration Schedule; Drug Evaluation, Preclinical; Ethinyl Estradiol; Facial Dermatoses; Female; Germany; Humans; Netherlands; Progesterone Congeners; Severity of Illness Index; Treatment Outcome | 2002 |
10 other study(ies) available for drospirenone and Acne
| Article | Year |
|---|---|
Anti-androgenic therapy in young patients and its impact on intensity of hirsutism, acne, menstrual pain intensity and sexuality - a preliminary study.
Topics: Acne Vulgaris; Adult; Androgen Antagonists; Androstenes; Contraceptives, Oral; Cyproterone; Dysmenorrhea; Female; Hirsutism; Humans; Prospective Studies; Quality of Life; Sexuality; Young Adult | 2019 |
Oral contraceptives for acne treatment: US Dermatologists' knowledge, comfort, and prescribing practices.
Topics: Acne Vulgaris; Androstenes; Contraceptives, Oral; Cross-Sectional Studies; Dermatologists; Female; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Male; Practice Patterns, Physicians' | 2017 |
Very low dose of flutamide in the treatment of hyperandrogenism.
Topics: Acne Vulgaris; Adolescent; Androgen Antagonists; Androstenes; Dose-Response Relationship, Drug; Drug Therapy, Combination; Ethinyl Estradiol; Female; Flutamide; Hirsutism; Humans; Hyperandrogenism; Norpregnenes; Treatment Outcome; Young Adult | 2018 |
Hyperandrogenic women treated with a continuous-regimen oral contraceptive.
Topics: Acne Vulgaris; Adolescent; Androgens; Androstenes; Contraceptives, Oral, Combined; Dermatitis, Seborrheic; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Prospective Studies; Sex Hormone-Binding Globulin; Testosterone | 2013 |
Cost of Medications Recommended by Canadian Acne Clinical Practice Guidelines.
Topics: Acne Vulgaris; Adapalene; Administration, Cutaneous; Administration, Oral; Androgen Antagonists; Androstenes; Anti-Bacterial Agents; Benzoyl Peroxide; Canada; Clindamycin; Cyproterone Acetate; Dermatologic Agents; Doxycycline; Drug Combinations; Estrogens; Ethinyl Estradiol; Humans; Isotretinoin; Mineralocorticoid Receptor Antagonists; Minocycline; Practice Guidelines as Topic; Severity of Illness Index; Tetracycline | 2016 |
An oral contraceptive with 3 approved indications.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Premenstrual Syndrome | 2008 |
YAZ and the novel progestin drospirenone.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Ethinyl Estradiol; Female; Humans; Menstrual Cycle; Molecular Structure; Patient Satisfaction; Premenstrual Syndrome | 2008 |
Advances in the treatment of acne.
Topics: Acne Vulgaris; Adolescent; Adult; Androstenes; Anti-Infective Agents, Local; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Approval; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Tretinoin | 2008 |
Efficacy and tolerance of acne treatment using both spironolactone and a combined contraceptive containing drospirenone.
Topics: Acne Vulgaris; Adult; Androgen Receptor Antagonists; Androstenes; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Prospective Studies; Spironolactone; Treatment Outcome | 2008 |
Yasmin--an oral contraceptive with a new progestin.
Topics: Acne Vulgaris; Androstenes; Body Weight; Contraceptive Agents; Contraceptives, Oral, Combined; Female; Humans; Mineralocorticoid Receptor Antagonists; Progesterone Congeners; Progestins; Thromboembolism; Venous Thrombosis; Weight Gain | 2002 |